Commentary - (2016) Volume 5, Issue 2
Phospho-TCTP and Dihydroartemisinin: A Novel Therapeutic Opportunity in
Advance Breast Cancer
- Maria Lucibello1* and Filippo De Braud2
- 1Institute of Translational Pharmacology, National Research Council, Rome, Italy
- 2Medical Oncology Department, Pathology and Molecular Biology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
*Corresponding Author:
Maria Lucibello, Institute of Translational Pharmacology, National Research Council, Rome, Italy, Tel: +39 06 45488002
Email:
